68Ga DOTATATE PET/CT of Non-FDG-Avid Pulmonary Metastatic Hemangiopericytoma

被引：7

作者：

Hung, Te-Jui ^{[1
]}

Macdonald, William ^{[1
]}

Muir, Tracey ^{[1
]}

Celliers, Liesl ^{[1
]}

Al-Ogaili, Zeyad ^{[1
]}

机构：

[1] Fiona Stanley Hosp, Dept Nucl Med & Mol Imaging, Perth, WA, Australia

来源：

CLINICAL NUCLEAR MEDICINE | 2016年 / 41卷 / 10期

关键词：

hemangiopericytoma; Ga-68; DOTATATE; F-18-FDG; PET/CT; somatostatin receptor; INTRACRANIAL HEMANGIOPERICYTOMA; MESENCHYMAL TUMORS; SOMATOSTATIN;

D O I：

10.1097/RLU.0000000000001313

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

We present the FDG and Ga-68 DOTATATE PET/CT findings of a 68-year-old woman with pulmonary metastases 28 years after her initial diagnosis of central nervous system hemangiopericytoma. The largest of the pulmonary lesions showed prominent Ga-68 DOTATATE uptake with comparatively minimal FDG avidity. Hemangiopericytoma is a rare mesenchymal tumor that arises from malignant pericytes, cells that form the walls of capillaries and postcapillary venules. This case demonstrates the potential of radiolabeled somatostatin analogs as a therapeutic option in the setting of widespread metastatic disease.

引用

页码：779 / 780

页数：2

共 9 条

[1] 18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases [J].

Chan, W. S. W. ;

Zhang, J. ;

Khong, P. L. .

BRITISH JOURNAL OF RADIOLOGY, 2010, 83 (992) :E172-E174

[2] Localisation of mesenchymal tumours by somatostatin receptor imaging [J].

de Beur, SMJ ;

Streeten, EA ;

Civelek, AC ;

McCarthy, EF ;

Uribe, L ;

Marx, SJ ;

Onobrakpeya, O ;

Raisz, LG ;

Watts, NB ;

Sharon, M ;

Levine, MA .

LANCET, 2002, 359 (9308) :761-763

[3] High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours [J].

Hofman, Michael S. ;

Kong, Grace ;

Neels, Oliver C. ;

Eu, Peter ;

Hong, Emily ;

Hicks, Rodney J. .

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2012, 56 (01) :40-47

[4]

Kota G, 2013, CLIN NUCL MED, V38, P984, DOI 10.1097/RLU.0000000000000237

[5] Clinical Analysis of Intracranial Hemangiopericytoma [J].

Park, Byoung-Joo ;

Kim, Young-Il ;

Hong, Yong-Kil ;

Jeun, Sin-Soo ;

Lee, Kwan-Sung ;

Lee, Youn-Soo .

JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2013, 54 (04) :309-316

[6] Metastatic recurrence of an intracranial hemangiopericytoma 8 years after treatment: report of a case with emphasis on the role of PET/CT in follow-up [J].

Purandare, Nilendu C. ;

Dua, Sumeet G. ;

Rekhi, Bharat ;

Shah, Sneha ;

Sharma, Anshu R. ;

Rangarajan, Venkatesh .

CANCER IMAGING, 2010, 10 (01) :117-120

[7]

Reubi JC, 1996, CANCER RES, V56, P1922

[8] Intracranial hemangiopericytoma Clinical Experience and Treatment Considerations in a Modern Series of 40 Adult Patients [J].

Rutkowski, Martin J. ;

Jian, Brian J. ;

Bloch, Orin ;

Chen, Cheng ;

Sughrue, Michael E. ;

Tihan, Tarik ;

Barani, Igor J. ;

Berger, Mitchel S. ;

McDermott, Michael W. ;

Parsa, Andrew T. .

CANCER, 2012, 118 (06) :1628-1636

[9] PET and PET/CT with 68Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors [J].

Sollini, Martina ;

Erba, Paola Anna ;

Fraternali, Alessandro ;

Casali, Massimiliano ;

Di Paolo, Maria Liberata ;

Froio, Armando ;

Frasoldati, Andrea ;

Versari, Annibale .

SCIENTIFIC WORLD JOURNAL, 2014,

← 1 →